CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals

This publication has 62 references indexed in Scilit:

• Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform “Spotty Business”
  Journal of Virology, 2008
• Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus
  The Journal of Experimental Medicine, 2007
• Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover
  The Journal of Experimental Medicine, 2007
• Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses
  The Journal of Experimental Medicine, 2007
• An HIV Vaccine — Evolving Concepts
  New England Journal of Medicine, 2007
• High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects
  The Journal of Infectious Diseases, 2005
• Comparative studies of Avipox-GM-CSF versus recombinant GM-CSF protein as immune adjuvants with different vaccine platforms
  Vaccine, 2005
• Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines
  Journal of Virology, 2003
• Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
  Journal of Virology, 2000
• Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1985